These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Growth inhibition of melanoma cells by interferons in vitro. Similar antiproliferative effects of 100-1000 times lower concentrations of nIFN-beta in comparison with rIFN-alpha-2a].
    Author: Zouboulis C, Garbe C, Orfanos CE.
    Journal: Hautarzt; 1989 Feb; 40(2):65-9. PubMed ID: 2714987.
    Abstract:
    The type I interferons (IFNs) rIFN-alpha 2a and nIFN-beta showed a significant dose-dependent antiproliferative effect on melanoma cell monolayer cultures in vitro compared with untreated controls (P less than 0.01 at 10 IU/ml; P less than 0.01 and P less than 0.001 at 1,000 IU/ml). The antiproliferative effect of a single IFN dose lasted for a maximum of 4 days, after which uninhibited proliferation of melanoma cells was again observed. In all experiments nIFN-beta showed a similar antiproliferative effect to rIFN-alpha 2a on the two melanoma cell lines (StML-11, SKMel-28) tested, when used in concentrations 100-1,000 times lower. At concentrations of 10,000 IU/ml rIFN-alpha 2a and 100-1,000 IU/ml hIFN-beta cytotoxic effects were observed.
    [Abstract] [Full Text] [Related] [New Search]